Drugmaker PTC Therapeutics raises $125M in IPO

Published



SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. raised more than $125 million after the drug developer priced an initial public offering of its stock near the top end of the range it expected.

The South Plainfield, N.J., company said it expects proceeds of about $114.2 million after deducting underwriting discounts and commissions.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.